1 |
Rosenberg, S. 2001. Recent advances in the molecular biology of hepatitis C virus. J. Mol. Biol. 313: 451-464.
DOI
ScienceOn
|
2 |
Xiong, S., J. Fan, and K. Kitazato. 2010. The antiviral protein cyanovirin-N: The current state of its production and applications. Appl. Microbiol. Biotechnol. 86: 805-812.
DOI
ScienceOn
|
3 |
Scarselli, E., H. Ansuini, R. Cerino, R. M. Roccasecca, S. Acali, G. Filocamo, et al. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21: 5017-5025.
DOI
ScienceOn
|
4 |
Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, et al. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA. 102: 9294-9299.
DOI
ScienceOn
|
5 |
Benedicto, I., F. Molina-Jimenez, B. Bartosch, F. L. Cosset, D. Lavillette, J. Prieto, et al. 2009. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J. Virol. 83: 8012-8020.
DOI
ScienceOn
|
6 |
Blanchard, E., S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson, C. Wychowski, and Y. Rouille. 2006. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80: 6964-6972.
DOI
ScienceOn
|
7 |
Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11: 791-796.
DOI
ScienceOn
|
8 |
Wasley, A. and M. J. Alter. 2000. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin. Liver Dis. 20: 1-16.
DOI
ScienceOn
|
9 |
Zeisel, M. B., G. Koutsoudakis, E. K. Schnober, A. Haberstroh, H. E. Blum, F. L. Cosset, et al. 2007. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46: 1722-1731.
DOI
ScienceOn
|
10 |
Evans, M. J., T. von Hahn, D. M. Tscherne, A. J. Syder, M. Panis, B. Wolk, et al. 2007. Claudin-1 is a hepatitis C virus coreceptor required for a late step in entry. Nature 446: 801-805.
DOI
ScienceOn
|
11 |
Helle, F. and J. Dubuisson. 2008. Hepatitis C virus entry into host cells. Cell Mol. Life Sci. 65: 100-112.
DOI
ScienceOn
|
12 |
Higginbottom, A., E. R. Quinn, C. C. Kuo, M. Flint, L. H. Wilson, E. Bianchi, et al. 2000. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J. Virol. 74: 3642-3649.
DOI
ScienceOn
|
13 |
Johansson, D. X., C. Voisset, A. W. Tarr, M. Aung, J. K. Ball, J. Dubuisson, and M. A. A. Persson. 2007. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc. Natl. Acad. Sci. USA. 104: 16269-16274.
DOI
ScienceOn
|
14 |
Kato, T., T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, M. Mizokami, and T. Wakita. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125: 1808-1817.
DOI
ScienceOn
|
15 |
Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, et al. 1998. Binding of hepatitis C virus to CD81. Science 282: 938-941.
DOI
ScienceOn
|